Core Scientific, Inc. (CORZ)
USD 14.45
(-9.86%)
USD 14.45
(-9.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 65.11 Million | 205.18 Million | -56.73 Million | -23.76 Million | -832 Thousand |
| Net Income | -246.48 Million | -2.14 Billion | 47.31 Million | -12.2 Million | -11.92 Million |
| Depreciation & Amortization | 96.44 Million | 226.09 Million | 33.36 Million | 9.4 Million | 6.11 Million |
| Deferred income taxes | - | -18.52 Million | 9.52 Million | - | - |
| Stock-based compensation | 58.89 Million | 182.89 Million | 38.93 Million | 3.03 Million | 2.88 Million |
| Change in working capital | 551.03 Million | 478.66 Million | -49.51 Million | -21.12 Million | 5.68 Million |
| Other non-cash items | -260.83 Million | 2.09 Billion | -1.3 Million | -4.82 Million | -3.59 Million |
| Investing Cash Flow | -2.99 Million | -590.77 Million | -423.84 Million | -15.14 Million | -37.36 Million |
| Investments in PPE | -16.16 Million | -383.98 Million | -59.27 Million | -1.56 Million | -37.41 Million |
| Acquisitions | - | - | -365.21 Million | -13.66 Million | - |
| Investment purchases | - | - | -59.27 Million | - | - |
| Sales/Maturities of investments | - | 10.85 Million | - | - | - |
| Other Investing Activities | 13.16 Million | -206.79 Million | 645 Thousand | 92 Thousand | 52 Thousand |
| Financing Cash Flow | -44.64 Million | 306.15 Million | 603.53 Million | 40.72 Million | 28.69 Million |
| Debt repayment | -40.99 Million | -113.29 Million | -49.28 Million | -38.08 Million | -832 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | -31.64 Million | - | - | - |
| Common Stock Issuance | - | 481.4 Million | 671.26 Million | 2.64 Million | 29.52 Million |
| Other Financing Activities | -3.65 Million | -30.31 Million | -18.45 Million | 2.64 Million | 29.52 Million |
| Accounts receivables | -744 Thousand | -7.57 Million | -7.4 Million | -1.54 Million | -83 Thousand |
| Accounts payables | 118.59 Million | 26.71 Million | -21.99 Million | -1.77 Million | - |
| Inventory | - | - | - | - | - |
| Other working capital | 433.18 Million | 459.52 Million | -20.12 Million | 31.56 Million | 5.76 Million |
| Cash at beginning of period | 52.24 Million | 131.67 Million | 8.72 Million | 6.9 Million | 16.4 Million |
| Cash at end of period | 69.7 Million | 52.24 Million | 131.67 Million | 8.72 Million | 6.9 Million |
| Capital Expenditure | -16.16 Million | -383.98 Million | -59.27 Million | -1.56 Million | -37.41 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 17.46 Million | -79.43 Million | 122.95 Million | 1.81 Million | -9.49 Million |
| Free Cash Flow | 48.95 Million | -178.79 Million | -116.01 Million | -25.33 Million | -38.24 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -804.89 Million | 210.69 Million | -246.48 Million | -195.69 Million | -41.14 Million | -9.26 Million |
| Depreciation & Amortization | 31.45 Million | 29.76 Million | 96.44 Million | 30.94 Million | 24.46 Million | 20.74 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 8.49 Million | -1.06 Million | 58.89 Million | 17.47 Million | 14.86 Million | 14.28 Million |
| Change in working capital | 79.05 Million | 133.45 Million | 551.03 Million | 265.46 Million | 90.02 Million | 78.74 Million |
| Other non-cash items | 763.81 Million | -282.36 Million | -260.83 Million | -103.06 Million | -28.61 Million | -36.49 Million |
| Investing Cash Flow | -3.18 Million | -31.97 Million | -2.99 Million | 2.36 Million | -2.86 Million | -619 Thousand |
| Investments in PPE | -3.13 Million | -31.89 Million | -16.16 Million | -11.64 Million | -2.74 Million | -235 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -49 Thousand | -76 Thousand | 13.16 Million | 14 Million | -126 Thousand | -384 Thousand |
| Financing Cash Flow | -15.19 Million | 54.36 Million | -44.64 Million | -18.29 Million | -15.38 Million | -9.94 Million |
| Debt repayment | -15.55 Million | -2.74 Million | -40.99 Million | -14.63 Million | -15.38 Million | -9.94 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 3.39 Million | -3.39 Million | - | - | - | - |
| Common Stock Issuance | 367 Thousand | 55 Million | - | - | - | - |
| Other Financing Activities | -3.39 Million | 2.91 Million | -3.65 Million | -3.65 Million | - | - |
| Accounts receivables | -3.56 Million | -106 Thousand | -744 Thousand | 108 Thousand | 150 Thousand | -1.08 Million |
| Accounts payables | -1.74 Million | -9.73 Million | 118.59 Million | 85.82 Million | 9.48 Million | 6.87 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 84.37 Million | 143.29 Million | 433.18 Million | 179.53 Million | 80.38 Million | 72.95 Million |
| Cash at beginning of period | 114.27 Million | 69.7 Million | 52.24 Million | 63.94 Million | 76.76 Million | 69.29 Million |
| Cash at end of period | 97.1 Million | 114.27 Million | 69.7 Million | 69.7 Million | 63.94 Million | 76.76 Million |
| Capital Expenditure | -3.13 Million | -31.89 Million | -16.16 Million | -11.64 Million | -2.74 Million | -235 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -17.17 Million | 44.56 Million | 17.46 Million | 5.76 Million | -12.81 Million | 7.46 Million |
| Free Cash Flow | -1.93 Million | -9.72 Million | 48.95 Million | 10.05 Million | 2.69 Million | 17.8 Million |
BRNL
SLLFF
ALKM
MBLINFRA
000880
EOGSF